We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A novel germline mutation of PTEN associated with brain tumours of multiple lineages.
- Authors
Staal, F J T; van der Luijt, R B; Baert, M R M; van Drunen, J; van Bakel, H; Peters, E; de Valk, I; van Amstel, H K P; Taphoorn, M J B; Jansen, G H; van Veelen, C W M; Burgering, B; Staal, G E J
- Abstract
We have identified a novel germline mutation in the PTEN tumour suppressor gene. The mutation was identified in a patient with a glioma, and turned out to be a heterozygous germline mutation of PTEN (Arg234Gln), without loss of heterozygosity in tumour DNA. The biological consequences of this germline mutation were investigated by means of transfection studies of the mutant PTEN molecule compared to wild-type PTEN. In contrast to the wild-type molecule, the mutant PTEN protein is not capable of inducing apoptosis, induces increased cell proliferation and leads to high constitutive PKB/Akt activation, which cannot be increased anymore by stimulation with insulin. The reported patient, in addition to glioma, had suffered from benign meningioma in the past but did not show any clinical signs of Cowden disease or other hereditary diseases typically associated with PTEN germline mutations. The functional consequences of the mutation in transfection studies are consistent with high proliferative activity. Together, these findings suggest that the Arg234Gln missense mutation in PTEN has oncogenic properties and predisposes to brain tumours of multiple lineages.
- Publication
British journal of cancer, 2002, Vol 86, Issue 10, p1586
- ISSN
0007-0920
- Publication type
Journal Article
- DOI
10.1038/sj.bjc.6600206